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Abstract
The emergence of whole genome sequencing (WGS) technologies as primary research tools has
allowed for the detection of genetic diversity in Mycobacterium tuberculosis (Mtb) with
unprecedented resolution. WGS has been used to address a broad range of topics, including the
dynamics of evolution, transmission and treatment. Here, we have analyzed 55 publically
available genomes to reconstruct the phylogeny of Mtb, and we have addressed complications that
arise during the analysis of publically available WGS data. Additionally, we have reviewed the
application of WGS to the study of Mtb and discuss those areas still to be addressed, moving from
global (phylogeography), to local (transmission chains and circulating strain diversity), to the
single patient (clonal heterogeneity) and to the bacterium itself (evolutionary studies). Finally, we
discuss the current WGS approaches, their strengths and limitations.
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1) Intro
With the rapid development of whole genome sequencing (WGS) technologies, we have
unprecedented capacity to detect genetic diversity in Mycobacterium tuberculosis (Mtb).
WGS is particularly powerful when applied to Mtb, which is characterized by a relatively
low amount of genetic diversity. WGS data has allowed us to reconstruct the phylogeny of
Mtb, and in the process learn a great deal about it's geographic distribution1,2. More
recently, studies have investigated the dynamics of evolution, transmission and treatment
across shorter time scales3–7 By sequencing strains from small outbreaks and single
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infections, groups have sought to understand the unique evolutionary dynamics inherent in
the spread of tuberculosis5. Using WGS, we can address a broad range of topics - from
questions on the transmission and fitness of clinical strains to how Mtb evolves over long
and short time scales. Here we have reviewed the insights gained from the use of WGS and
discuss those areas still to be addressed, moving from global (phylogeography), to local
(transmission chains and circulating strain diversity), to the single patient (clonal
heterogeneity), to the bacterium itself (evolutionary studies), and finally discussing the
platform of WGS, its strengths and current limitations.
2) Global Diversity
WGS has been proposed as a sort of “gold standard” for strain typing in Mtb. As such, it
clarifies previous strain typing approaches used for phylogenetic and epidemiologic studies.
The standard genotyping methods are based on repetitive elements that provide limited
functional information and are highly prone to convergent evolution, limiting their
application to phylogenic reconstructions. The discriminative power of these methods
varies, the results of different methods do not always agree, and the diversity of the markers
can complicate the analysis1,8. For example, Niemann et al sequenced two isolates of the
rapidly spreading Mtb Beijing genotype clone from a high incidence region
(Karakalpakstan, Uzbekistan)9. The isolates possessed the same genotype by IS6110
restriction fragment length polymorphism (RFLP) and mycobacterial interspersed repetitive
unit – number tandem repeat (MIRU-VNTR) patterns; however, WGS demonstrated that
they differed at 131 separate sites, including one large deletion. Thus, typing methods can
miss substantial amounts of genetic diversity, and where the overall diversity of circulating
clones is limited, standard typing measures are insufficient to discriminate between strains.
As the cost of WGS drops, it is more feasible to consider WGS as a primary tool for the
typing of Mtb strains that is not subject to the limitations of standard methodologies.
However, use of WGS sequence data is subject to its own set of errors. To demonstrate the
power and the pitfalls of this approach, we undertook a phylogenetic analysis of Mtb strains
using all of the publically available Mtb genomes. We utilized 55 whole (or nearly whole)
genomes downloaded and assembled from GenBank, the Broad Institute, or obtained
through personal communication from the authors of published papers by January 15 of
2011 (Table 1). While each genome included more than 4 million bases, these genomes
were not fully assembled, nor were they annotated in the same manner. To enable an
inclusive comparison, we blasted these genomes against annotated genes of the reference
strain F11 to form multiple strain alignments for each gene, including all available strains.
Variable sequence positions or SNPs, where at least 1 of 55 sequences differed from other
sequences, were then extracted and concatenated, in the order they appear in the reference
F11 genome, to create an abbreviated multiple alignment of SNP positions from all 55
sequences. A phylogenetic tree was built from these sequences by molecular parsimony
using PAUP10 (Figure 1A). Genes or regions of the genes that were misaligned, where one
or several sequences had a high density of SNPs in close proximity, indicating possible
either sequencing or alignment problems, were excluded from the analysis using a
computational clean-up algorithm; the resulting trees are provided in Figure 1. The 17740
aligned positions were in 3324 genes and included a mutation in at least one of 55 strains
that differed from the other sequences.
The relatively high number of SNPs we identified is in part the result of natural variation, as
we have included all genes from 55 nearly complete globally diverse strains, and it is in part
a consequence of the technical error present in some sequences. In particular, several strains
out of the 55 available were highly enriched in regional clusters of SNPs, suggesting
potentially problematic base calls (Table 1). The number of clustered SNPs was unusually
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high in several strains (8 strains have greater than 1000 regional clusters of SNPS), which
indicates these sequences tended to be noisier than the others. While such clustered SNP
regions were excluded from our phylogenetic analysis, the not-clustered, stand-alone SNPs
in those same strains were included in our collection of SNPs for phylogenetic analysis. It is
difficult to algorithmically resolve whether any given mutation is of biological origin or is a
sequencing artifact. Not surprisingly, the strains that have the highest number of clustered
SNPs (Table 1) also have unusually long terminal branches (Figure 1A), a further indication
of a higher frequency of sequencing error in these strains. As our intent was to review the
whole genome data currently publically available, however, we included all 55 sequences
here. While the long terminal branch lengths are likely to be contributed to by sequencing
error, the approximate location of these sequences in the tree is of interest, as the
phylogenetically informative SNPs that determine the branching order are likely to be valid.
Also, all 55 genomes may offer useful sequence information in particular genes of interest.
However, potential problems in these strains should be considered for any subsequent
analysis. In particular, polymorphisms relating to drug-resistance, and further studies based
on these whole genomes should include manual inspection of the alignments.
The reconstructed phylogeny of 55 whole genomes (Figure 1A) was compared to a
phylogeny based on a minimal set 45 SNP positions determined by Filliol et al1 to be
sufficient to resolve and differentiate Mtb and M.bovis isolates (Figure 1B). In general, all
main lineages were preserved and there is a high level of correspondence between the two
trees. Two of the three Beijing strain sub-lineages present in the whole genome tree
converged into 1 sub-lineage in the 45-SNP tree. Additionally, F11, the KZN strains, and the
SUMu strains from Canada were related but clearly distinguishable on the whole genome
tree, but they were collapsed on the 45-SNP trees. In contrast, one sub-lineage of the Beijing
genotype formed its own lineage on the 45 SNP trees (orange cluster, Figure 1A, 1B).
Similarly, H37 and close SUMu strains from Canada appeared further from F11, KZN and
other SUMu strains from Canada on the 45-SNP tree than they appeared on a whole genome
tree. Taken together, this confirms that the 45 positions determined by Filliol et al can
successfully resolve the same main lineages that appear in the whole genome analysis and
thus can be used for initial characterization of isolates, but WGS provides added resolution
which may be of value to applications that require finer resolution data.
Whenever available for the near full-length genomes, we recorded isolate's sample history:
the year and geographic location of isolate collection, and patient history including place of
birth and drug resistance status (Table 1). This allowed us to relate the isolates phylogeny
with their geographic location and the date of sampling (Figure 2). In agreement with Filliol
et al, the 55 whole genomes fall into 7 major lineages. We found 4 distinctive sub-lineages
of the Beijing strain: 2 sub-lineages formed from strains isolated in USA in 1990–1998 and
2 sub-lineages formed from strains isolated in Western Cape, South Africa. Perhaps not
surprisingly, one of the South African Beijing lineages also includes a strain isolated in San
Francisco in 2002 (Table 1, Figure 2).
In agreement with previous studies1,2,9, the tree revealed large genetic distance between
isolates that were designated related to the Beijing strain. The distances between different
strains within the Beijing sub-lineages appear to be roughly comparable to the distances
between different F11 and KwaZulu Natal (KZN) lineages, hence the latter are marked by
the same light green background color on Figure 2. The distances between the F11 / KZN
sub-cluster and Canadian SUMu sequences and H37Rv and H37Ra (colored in distinct
shades of green on Figure 2) are comparable to the distances between Beijing sub-clusters.
Thus the genetic distances in the hierarchy of relationships in TB lineages are not always
consistently represented by commonly used nomenclature conventions and reference strains.
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2) Local Diversity
WGS derived phylogenies build a framework upon which questions about evolution,
transmission, and drug resistance can be asked. The last of these is of particular interest as
drug resistant strains have stymied the treatment of tuberculosis, leading to the need for
novel therapeutics and carefully designed treatment regimens. When different levels of drug
resistance are observed among highly related strains, such as the KZN strains and the
Beijing strains from the Western Cape of South Africa, it provides an opportunity for
improved clarity and resolution in mapping the acquisition and spread of drug resistance.
Using such comparisons, it has become clear that highly drug resistant strains are emerging
independently in the same geographic locale to a greater degree than previously appreciated.
For example, in the Western Cape region of South Africa, the Beijing XDR strains are
closely intermingled with MDR strains (Figure 2). Standard genotyping methods suggested
that the Beijing XDR strains emerged once but were undergoing clonal expansion and
transmission in the region. However, WGS-based phylogenetic analysis revealed the
independent appearance of distinct XDR resistance mutations within different MDR sub-
lineages of the Beijing genotype4. Similarly, in KwaZulu Natal, South Africa, the XDR
KZN strains, isolated in 2005 and 2006, have a slightly longer phylogenetic distance from
their most recent common ancestor of the KZN lineage than the MDR KZN strains, isolated
in 1994, suggesting at first glance that the XDR KZN strains evolved stepwise from the
MDR strains. However, upon further inspection of the WGS data, the XDR strains and
MDR strains have different rifampicin and pyrazinamide resistance mutations, indicating
that these strains emerged independently from monoresistant isolates3.
The high resolution of WGS based phylogenetic analysis has been informative in other
public health settings, most notably in the context of outbreak tracing. A recent outbreak of
Mtb was detected in Vancouver, British Columbia, and by standard typing methods, it was
defined as a single clonal outbreak5. The authors initially applied MIRU/VNTR to determine
a source case and transmission chain; however, the MIRU-VNTR pattern was identical
across all isolates and the addition of contact tracing did not reveal a source case. The
authors sequenced the genomes of 36 isolates, 32 from the outbreak and 4 historical isolates
from the region with an identical MIRU-VNTR pattern. Concatenation of polymorphic loci
and subsequent phylogenetic analysis revealed a dendrogram with two primary branches,
indicating two distinct transmission chains. Overlaying the phylogenetic analysis with a
social network analysis, Gardy et al identified the transmission chain through which the
infection spread. This study serves as the prototype for the use of WGS in outbreak tracing
for Mtb, demonstrating it's effectiveness particularly in low-endemic countries where even
high resolution (24-loci) MIRU-VNTR is likely to be uninformative.
3) Individual diversity
The resolution provided by WGS also allows researchers to investigate long-standing
assumptions about the nature of tuberculosis. While Mtb infection is typically thought to be
clonally homogeneous, recent studies have challenged this idea suggesting there is more
heterogeneity within the infecting bacterial population than expected11,12. There are several
potential mechanisms by which bacterial population heterogeneity might exist within a host
– (a) an individual may be simultaneously infected by multiple strains, (b) an individual
may be super-infected, or reinfected by a new strain, or (c) genetic diversity may arise in the
bacterial population spontaneously during the course of infection (Figure 3). While the level
of heterogeneity created by each of these mechanisms varies, WGS provides both the depth
of coverage and sensitivity necessary to accurately assess population heterogeneity and
begin to probe its functional consequences.
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Recurrent Mtb infection is a common clinical problem. Many studies have used a variety of
genotyping techniques to identify differences between the original strain and the recurrent
one. Where these strains are discordant, patients are typically assumed to have been infected
with a second strain13–18. Indeed, mixed infections have been reported to occur in up to 54%
of patients sampled19. Clinically, infection with multiple strains can lead to apparent
differences in drug susceptibility20–22, which may only be one aspect of the differences
between strains16 making diagnosis and treatment significantly more complicated. It is
likely that with additional investigation and better sampling methods, mixed infections will
be increasingly recognized, and the application of WGS will provide greater resolution in
these studies, indentifying genetically distinct though highly related strains.
Within-host evolution of strains is another important source of genetic heterogeneity, and
the principle source of de novo drug resistances. Saunders et al use deep resequencing of
serial sputum isolates to characterize genetic diversity in a single patient infected with drug
susceptible Mtb and in whom drug resistance evolved7. Serial isolates were obtained over a
12-month period from presentation with an initial drug susceptible infection through
stepwise development of multiple drug resistance. Interestingly, only mutations conferring
drug resistance were identified, with no additional mutations identified in non-repetitive
regions. These results emphasize the strong bottleneck created by antibiotic exposure, and
suggest that neither the host immune system nor exposure to antibiotics generates a
hypermutable state in Mtb. However, limits in sampling and tracking in vivo populations of
Mtb make it difficult to fully understand the evolutionary dynamics of patient isolates, and
such isolates can only be obtained from patients with active disease making it difficult to
assess the evolution of the bacterium throughout all stages of infection.
Indeed, until recently, it was assumed that Mtb has little capacity to acquire new mutations
in the host because the bacterium is presumed to be quiescent through much of that time.
However, by applying WGS to Mtb isolates from the cynomolgus macaque model, Ford et
al. have recently shown that the mutation rate (mutations/bp/day) in active and latent disease
is roughly equivalent, suggesting that bacteria continue to acquire genetic diversity, even
during latency6. Additionally, their results suggest that lesions are both genetically
independent and genetically distinct, such that bacteria sampled from one lesion may not
represent the true diversity present within the patient (Figure 3b). Thus, if extrapulmonary
dissemination occurs from any one lesion, the extrapulmonary sites would be genetically
related to that lesion but distinct from others. These results have particular relevance when
taken in the light of our primary sample source - sputa. Only bacteria present in cavitary
lesions open to the airway will be present in sputa samples, and the cavitary lesions
producing sputa may change dynamically during the course of infection as old lesions
resolve and new lesions form. Future studies investigating in-host bacterial diversity may
provide additional insight into these issues.
The overall picture of bacterial diversity is clearly a complex one – with diversity existing
between patients, within a patient, and within a lesion. Mixed Mtb infection (whether by
mixed inoculum, super-infection, or in-host evolution) raises a set of important questions.
Could apparent phenotypic classifications (such as drug resistance) based on culture
sometimes be incorrect due to mixed populations, leading to misdiagnosis in clinical
settings? Can we look at key SNPs from pooled sweeps of colonies to estimate their
frequencies in mixed cultures and rapidly detect low frequencies of drug resistance
mutations in an individual? Finally, is Mtb superinfection enhanced in HIV high prevalent
populations? For HIV-infected individuals, rapid HIV-1 depletion of Mtb-specific CD4 T
cells can aggravate Mtb infections23, raising the possibility that immune dysfunction in
HIV-infected people may make them more susceptible to serial Mtb infection, including
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superinfection with drug resistant strains. WGS will allow us to implement carefully crafted
studies to address these important questions.
4) Bacterial diversity
The accumulation of WGS data allows us to assess the genetic diversity across the genome,
seeking signatures of selective pressure. Selection can be quantified by relating the ratio of
nonsynonymous genetic changes to synonymous changes (dN/dS), where a dN/dS greater
than one is thought to reflect positive selection for increased diversity. Recently, Comas and
colleagues used WGS to assess selection in a panel of 21 clinical strains24. Not surprisingly,
essential genes had a lower dN/dS (0.53) than non-essential genes (0.66), indicating that
while the genome overall is under purifying selection, essential genes are under greater
purifying selective pressure. The authors then examined an experimentally defined set of T-
cell epitopes25, hypothesizing that these might represent regions of increased functional
diversity as a mechanism of immune evasion. Intriguingly, the T-cell epitopes analyzed
appear to show the greatest amount of sequence conservation, with a dN/dS less than that of
essential genes (0.25 for the epitope-coding region of the ORF). This may suggest that Mtb
growth and transmission requires T-cell recognition, and therefore that the bacterium
actually benefits from the host T-cell response. While further work is needed to clarify the
dynamics of host-pathogen co-evolution in Mtb, these early results suggest that Mtb may
depart from classic paradigms.
5) Challenges in WGS
While the capacity to perform low cost, high quality whole genome sequencing has
transformed phylogenetic and population analyses in Mtb, there are some limitations with
the current sequencing methodologies that can significantly skew our interpretation of the
data. Most of the analyses described above hinge on the power of WGS to identify SNPs.
Deletion or insertion of entire genes or large regions can be detected relatively easily (by
absence of expected reads, or presence of novel contigs relative to a reference genome), and
gene loss in particular has been frequently noted as a source of variability among
mycobacteria26–28. However, polymorphisms in repetitive regions, gene duplications,
chromosomal rearrangements, and copy-number changes of tandem repeats, are more
challenging to detect by next-generation sequencing methods, such as Illumina, and can
have significant biologic consequences. Paired-end read technology is quickly becoming the
standard in generating WGS data, and offers some solutions to the problem of resolving
these otherwise inaccessible regions.
Repetitive Regions
The limitations in sequencing repetitive regions apply to several genes and repeat elements
scattered throughout the Mtb genome. These include some lipid biosynthetic genes as well
as insertion elements, including IS6110, MIRUs and the clustered regularly interspaced
short palindromic repeats (CRISPR) elements, which have been exploited extensively for
strain typing. One example of the pitfalls associated with the sequencing of these regions has
emerged from the debate over whether there is indeed purifying selection on T cell epitopes
as suggested by Comas et al24. Uplekar et al. recognized that the genes encoding many of
the ESX proteins, a family of secreted proteins that are represent strong CD4 and CD8 T cell
antigens, were extremely homologous and thus poorly assessed by Illumina technology.
Thus, the authors used Sanger sequencing to resequence these genes from a panel of clinical
isolates and found, contrary to the previously mentioned report, that some of these genes are
highly polymorphic, in part because of high levels of recombination29. When this diversity
is taken into account, these antigens appear to be under diversifying selection. Similarly
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other important antigens including the PE and PPE genes are simply not accessible to short
read sequencing technology and thus may obscure significant antigenic variation.
Genomic Duplications
Large-scale genomic duplications have been observed among mycobacterial strains, and in
some cases, are postulated to have an influence on phenotype. For example, some members
of the Beijing strain family have recently been found to have a large-scale duplication of
~350kb in the region of Rv3128c to Rv3427c30, including DosR, the transcriptional
regulator of the hypoxic response31. This type of polymorphism is difficult to detect with
short reads because there are multiple alternative ways to build contigs, producing ambiguity
in assembly.
Current advances in data analysis, including de Bruijn graph methods32 and methods of
statistical analysis33 are designed to detect signatures of large duplications, often using
variations in depth of coverage to detect when large regions have been copied.
Genomic rearrangements
Genome rearrangements are difficult to detect with short reads because of the localized
nature of the lesion. Genomic sequence on either side of the cross-over point might be well-
covered by reads, but detection of the rearrangement point itself requires longer reads (e.g.
from Roche 454) that span the discontinuity, or paired-end/mate-pair data as evidence of the
connectivity. However, genome rearrangements have not been reported among M.
tuberculosis strains (although there is a chromosomal inversion between M. tuberculosis and
M. leprae34. The wild-type (drug-sensitive) KZN 4207 strain isolate from the KwaZulu-
Natal region of South Africa was initially reported to have an inversion
(http://www.broadinstitute.org/annotation/genome/mycobacterium_tuberculosis_spp/),
although sequencing of the same strain in another lab did not find evidence for this
inversion3. In practice, the large-scale genomic stability of Mtb justifies the use of a
comparative assembly approach35 in which sequencing data for new M. tuberculosis strains
are aligned against H37Rv, F11, or the genome sequence of another representative strain for
comparative analysis.
6) Conclusion
Because of the paucity of genetic diversity in Mtb, WGS is a uniquely powerful tool,
providing both the sensitivity to detect rare genetic events, and the broad applicability to
detect multiple forms of genetic change. Already, we have learned a great deal about the
bacterium and the nature of the disease. Early reports show surprising amounts of
heterogeneity in bacterial populations, even between strains with identical MIRU/VNTR,
RFLP patterns, or spoligotypes. Many questions remain, however. Perhaps chief amongst
these is the true nature of in-host diversity: its clinical consequences and the mechanisms
behind it. WGS has the capacity to address these and other questions with minimal bias and
unprecedented sensitivity. However, it will be important to remember that current WGS
methodologies do not cover all regions of the genome and there is likely to be important
biology hidden in these uncharted areas.
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BOX : Questions to be addressed by WGS
1) Could apparent phenotypic classifications (such as drug resistance) based on
culture sometimes be incorrect due to mixed populations, leading to
misdiagnosis in clinical settings?
2) Can we look at key SNPs from pooled sweeps of colonies to estimate their
frequencies in mixed cultures and rapidly detect low frequencies of DR
mutations in an individual?
3) What is the true extent of Mtb in-host heterogeneity, and is it enhanced in
HIV positive populations?
4) Are certain hosts or host microenvironments more conducive to the
development of genetic diversity?
5) How can sequencing technology be modified and enhanced to allow for the
complete de-novo assembly of the Mtb genome, including GC-rich repetitive
regions?
6) Given the relatively limited sampling of XDR Mtb strains (Figure 2), the
global dissemination of XDR Mtb (provide WHO web link?), and the fact
that drug resistance can evolve independently in individuals under treatment,
will novel mechanisms of drug resistance be identified through more
extensive sampling and contrasting drug resistance profiles using WGS?
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Figure 1. Comparison of phylogenies based on whole genome and targeted SNPs from the
available WGS data (Table 1)
The phylogenies were reconstructed using molecular parsimony in PAUP software10.
Different lineages are colored in distinct colors, with sub-lineages colored in different
shades of the same color. The coloring scheme is preserved between A and B figures.
A) Parsimony tree based on 17740 SNP positions taken from 3324 genes, where at least 1 of
55 sequences differed from other sequences. SNPs were extracted from multiple sequence
alignments created for each gene using the following algorithm. Each annotated gene, from
a total of 3941 genes for the reference strain F11 from GenBank, was used to perform pair-
wise BLASTN search against the other 54 whole genomes. If multiple partial sequences in a
genome were found to be homologous to the same gene in F11, we selected the version with
the longest coverage, requiring minimum similarity score of 75% and minimum length of
coverage of 75%. If the resulting partial sequence was shorter than the gene in F11, it was
augmented by adjacent chromosome sequence to the length of the gene of F11. The
homologous genes from 55 strains were then assembled into files so that each gene (except
for three genes which were uniquely found in F11) had a corresponding file. After
assembling homologous sequences, the sequences were aligned using MUSCLE (version
3.8.31) downloaded from www.drive5.com to generate nucleotide multiple sequence
alignments for homologous gene files (total 3596) that has at least one non-identical
sequence. Since in some strains N- and/or C-terminal gene ends were augmented compared
to original BLASTN hit to reflect the full length of the gene in F11, they could be in fact not
homologous to F11. In this case these ends did not align within F11 gene and were excluded
from the alignment according to F11 gene start and end positions. The resulting gene
alignments were then used to generate artificial SNP sequences, which contained a
concatenated version of all positions where a SNP was identified (where at least 1 of 55
sequences differed from other sequences). To minimize inclusion of sequencing errors in
these artificial SNP sequences, we excluded SNPs that appeared to be clustered in a local
region, specifically where three SNPs were found in a 10 base pair window when compared
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to genes in F11. Furthermore we manually checked the files that have are enriched for
clusters of mutations and excluded 70 problematic files. Sequences that are highly enriched
for clusters of potentially problematic bases (Table 1) are indicated with the stars. The
strains that have the highest number of clustered SNPS (Table 1) also have unusually long
terminal branches, a further indication of sequencing artifacts in these strains.
B) Parsimony tree based on 45 SNP positions from Filliol et al1 taken from the same set of
55 genomes.
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Figure 2. Phylogenetic lineages and geographic mapping
Whenever available for the near full-length genomes, we recorded isolate's sample history:
the year and geographic location of isolate collection, and patient history including place of
birth and drug resistance status (Table 1). This allowed us to relate the isolates phylogeny
with their geographic location and the date of sampling. Lower part of the figure: same
phylogenetic tree that as shown in Figure 1A. The numbers on the brunches represent
bootstrap values obtained using 200 bootstrap replicates. Sequence names are removed
except several reference strains, but the most relevant information (genotypes, isolation
place, year of sampling) is noted on the tree. As in Figure 1A, sequences that are highly
enriched for clusters of potentially problematic bases (Table 1) are indicated with the stars.
Each lineage is shown with a distinct background box color, which corresponds to the colors
of Figure 1. The sub-lineages are shown with the shades of the same background box color.
For example, the Beijing strain-related lineage is shown in shades of yellow and orange.
Additionally, drug resistance status is indicated by branch color. 4 colors for branches are
used: black – drug resistant status of the strain is unknown; blue -- drug susceptible (DS);
green – mono-resistant to INH or multi-drug resistant (MDR); red – extensively drug
resistant (XDR), or pre-XDR (resistant to either fluoroquinolones or aminoglycosides).
Arrows that are the same color as the background boxes from which they originate show the
geographic places of the sequence isolation on the world map at the upper portion of the
figure. The black, blue, green and red circles on the map correspond to the drug status of the
isolates, the same coloring scheme as in the tree. The relative size of the circles corresponds
to the number of whole genomes isolated in the particular location. The dashed black arrows
pointing to the black circle in California represent isolates that were sequenced in San
Francisco from patients that were born in India, China, South Korea and The Phillipines.
The more detail geographic distribution of whole genome isolates from South Africa is
shown on insert at the right lower corner of the figure.
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Figure 3.
A) In-host heterogeneity complicates the study of the genetic diversity and makes treatment
and diagnosis of tuberculosis more difficult. There are several potential mechanisms by
which heterogeneity might exist within the host – (a) a host may be simultaneously infected
by multiple strains, (b) a host may be super-infected, or reinfected by a new strain, or (c)
heterogeneity may arise spontaneously during the course of infection. B) Experimental
results suggest that lesions are both genetically independent and genetically distinct, such
that bacteria sampled from one lesion may not represent the true diversity present within the
patient. Thus sputa samples are likely to under-estimate the amount of diversity present
within a single patient, and serial sputa samples may not originate from the same lesion
within the host.
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